Literature DB >> 21625934

Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.

Hee Jin Kim1, Han-Joon Kim, Jee-Young Lee, Ji Young Yun, So Yeon Kim, Sung Sup Park, Beom S Jeon.   

Abstract

The data regarding whether parkin genotype attributes phenotypic variation are conflicting. Since the incidence of parkin mutations is very low in patients with an age at onset (AAO) of >40 years, previous studies have unfairly compared phenotypes of two early onset Parkinson's disease (EOPD) groups with different AAOs. Thus, we compared the clinical features between patients with and without parkin mutations in EOPD with an AAO of ≤40 years. Of the 124 patients with EOPD with an AAO of ≤40 years who were recruited and screened for parkin mutations, 84 completed assessments for comparison of the phenotype according to parkin genotype. Fourteen of the 84 subjects carried two parkin mutations; 6, a single mutation; and 64, no mutations. Patients with two mutations had significantly younger AAOs, longer duration of PD, and more common family history than patients without parkin mutations. Otherwise, motor and nonmotor symptoms did not differ between them. Subgroup analysis of EOPD with an AAO of ≤35 years revealed similar results. Phenotype of EOPD may depend on early AAOs rather than presence of parkin mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21625934     DOI: 10.1007/s00415-011-6110-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  42 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

Review 2.  Nonmotor symptoms in genetic Parkinson disease.

Authors:  Meike Kasten; Lena Kertelge; Norbert Brüggemann; Joyce van der Vegt; Alexander Schmidt; Vera Tadic; Carsten Buhmann; Susanne Steinlechner; Maria Isabel Behrens; Alfredo Ramirez; Ferdinand Binkofski; Hartwig Siebner; Heiner Raspe; Johann Hagenah; Rebekka Lencer; Christine Klein
Journal:  Arch Neurol       Date:  2010-06

3.  Systematic examination of DNA variants in the parkin gene in patients with Parkinson's disease.

Authors:  Tao Wang; Zhi-hou Liang; Sheng-gang Sun; Xue-bing Cao; Hai Peng; Hong-jin Liu; E-tang Tong
Journal:  Chin Med J (Engl)       Date:  2004-10       Impact factor: 2.628

4.  Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

Authors:  C M van Duijn; M C Dekker; V Bonifati; R J Galjaard; J J Houwing-Duistermaat; P J Snijders; L Testers; G J Breedveld; M Horstink; L A Sandkuijl; J C van Swieten; B A Oostra; P Heutink
Journal:  Am J Hum Genet       Date:  2001-07-02       Impact factor: 11.025

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.

Authors:  Ruey-Meei Wu; Rebecca Bounds; Sarah Lincoln; Mary Hulihan; Chin-Hsien Lin; Wuh-Liang Hwu; Judy Chen; Katrina Gwinn-Hardy; Matt Farrer
Journal:  Arch Neurol       Date:  2005-01

8.  Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?

Authors:  D Verbaan; S Boesveldt; S M van Rooden; M Visser; J Marinus; M G Macedo; Y Fang; P Heutink; H W Berendse; J J van Hilten
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

9.  Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.

Authors:  J-Y Kim; S Y Kim; J-M Kim; Y K Kim; K-Y Yoon; J Y Kim; B C Lee; J S Kim; S H Paek; S S Park; S E Kim; B S Jeon
Journal:  Neurology       Date:  2009-04-21       Impact factor: 9.910

10.  Prevalence of smell loss in Parkinson's disease--a multicenter study.

Authors:  A Haehner; S Boesveldt; H W Berendse; A Mackay-Sim; J Fleischmann; P A Silburn; A N Johnston; G D Mellick; B Herting; H Reichmann; T Hummel
Journal:  Parkinsonism Relat Disord       Date:  2009-01-11       Impact factor: 4.891

View more
  9 in total

1.  Reduced expression of PARK2 in manganese-exposed smelting workers.

Authors:  Ximin Fan; Ying Luo; Qiyuan Fan; Wei Zheng
Journal:  Neurotoxicology       Date:  2017-08-18       Impact factor: 4.294

Review 2.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

3.  Does rate of progression run in essential tremor families? Slower vs. faster progressors.

Authors:  Elan D Louis; Nora Hernandez; Iuliana Ionita-Laza; Ruth Ottman; Lorraine N Clark
Journal:  Parkinsonism Relat Disord       Date:  2012-10-31       Impact factor: 4.891

4.  The Phenotypic Variation of a Parkin-Related Parkinson's Disease Family and the Role of Heterozygosity.

Authors:  Robert S Stark; Julia Walch; Georg Kägi
Journal:  Mov Disord Clin Pract       Date:  2019-09-16

Review 5.  PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

Authors:  Dominika Truban; Xu Hou; Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

6.  Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.

Authors:  Bárbara Mendes-Pinheiro; Fábio G Teixeira; Sandra I Anjo; Bruno Manadas; Leo A Behie; António J Salgado
Journal:  Stem Cells Transl Med       Date:  2018-09-20       Impact factor: 6.940

Review 7.  Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jingxuan Huang; Yangfan Cheng; Chunyu Li; Huifang Shang
Journal:  Transl Neurodegener       Date:  2022-04-08       Impact factor: 8.014

8.  Parkin disease: a clinicopathologic entity?

Authors:  Karen M Doherty; Laura Silveira-Moriyama; Laura Parkkinen; Daniel G Healy; Michael Farrell; Niccolo E Mencacci; Zeshan Ahmed; Francesca M Brett; John Hardy; Niall Quinn; Timothy J Counihan; Timothy Lynch; Zoe V Fox; Tamas Revesz; Andrew J Lees; Janice L Holton
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

9.  Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation.

Authors:  Aikaterina Angeli; Niccolo E Mencacci; Raquel Duran; Iciar Aviles-Olmos; Zinovia Kefalopoulou; Joseph Candelario; Sarah Rusbridge; Jennifer Foley; Priyanka Pradhan; Marjan Jahanshahi; Ludvic Zrinzo; Marwan Hariz; Nicholas W Wood; John Hardy; Patricia Limousin; Tom Foltynie
Journal:  Mov Disord       Date:  2013-07-01       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.